PDI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Perit Dial Int 29(3): 297-302
2009
© 2009 International Society for Peritoneal Dialysis
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davenport, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davenport, A.

Clinical

PERITONITIS REMAINS THE MAJOR CLINICAL COMPLICATION OF PERITONEAL DIALYSIS: THE LONDON, UK, PERITONITIS AUDIT 2002–2003

Andrew Davenport

UCL Centre for Nephrology, Royal Free & University College Medical School, London, United Kingdom

Correspondence to: A. Davenport, UCL Centre for Nephrology, Royal Free & University College Medical School, Rowland Hill Street, London NW3 2PF United Kingdom. andrew.davenport{at}royalfree.nhs.uk

{diamondsuit} Background: Over the past two decades, the rate of peritonitis in patients treated by peritoneal dialysis (PD) has been significantly reduced. However, peritonitis remains a major complication of PD, accounting for considerable mortality and hospitalization among PD patients.

{diamondsuit} Objective: To compare the outcome of peritonitis in a large unselected group of PD patients with that from single-center and selected groups.

{diamondsuit} Method: We audited the outcome of peritonitis in PD patients attending the 12 PD units in the Thames area in 2002 and 2003. There were 538 patients on continuous ambulatory PD (CAPD) and 325 patients on automated PD (APD) and/or continuous cycling PD (CCPD) at the end of 2002, and 635 CAPD and 445 APD/CCPD patients at the end of 2003.

{diamondsuit} Results: There were 1467 episodes of PD peritonitis during the 2-year period, including 129 recurrent episodes, with the average number of months between peritonitis episodes being 14.7 for CAPD and 18.1 for APD/CCPD, p < 0.05. However there was considerable variation between units. Coagulase-negative staphylococcus (CoNS) was the most common cause, accounting for around 30% of all peritonitis episodes, including recurrences, followed by non-pseudomonas gram negatives and Staphylococcus aureus. Cure rates were 77.2% for CoNS, 46.6% for S. aureus, and 7.7% for methicillin-resistant S. aureus. The cure rate for pseudomonas was 21.4%, and other gram negatives 56.7%. In total, there were 351 episodes of culture-negative peritonitis, with an average cure rate of 76.9%. Cure rates were higher for those centers that used a combination of intraperitoneal gentamicin and cephalosporins than those centers that used oral-based regimes. A total of 296 PD catheters were removed as a direct consequence of PD peritonitis: 121 due to gram-positive and 123 due to gram-negative organisms. Only 49 catheters were reinserted and the patients returned to PD. 52 patients died during or subsequent to their episode of PD peritonitis, with an overall mortality rate of 3.5%.

{diamondsuit} Conclusion: This audit showed that, in a large unselected population of PD patients, the incidence of peritonitis was significantly greater than that reported in single-center short-term studies, and varied from unit to unit. Similarly, the success of treating PD peritonitis varied not only with the cause of the infection but also from unit to unit. PD peritonitis remains a major cause of patients discontinuing PD and switching to hemodialysis.

KEY WORDS: Peritonitis; audit; icodextrin; infection.

Received 15 May 2008; accepted 30 September 2008.




This article has been cited by other articles:


Home page
pdiHome page
B. Afsar, R. Elsurer, A. Bilgic, S. Sezer, and F. Ozdemir
Regular Lactulose Use Is Associated with Lower Peritonitis Rates: an Observational Study
Perit. Dial. Int., March 1, 2010; 30(2): 243 - 246.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
B. Piraino
Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis. Was it effective?
Nephrol. Dial. Transplant., February 1, 2010; 25(2): 349 - 352.
[Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
M. P. Romero Gomez, A. Garcia-Perea, G. Ruiz Carrascoso, M. A. Bajo, and J. Mingorance
Campylobacter fetus Peritonitis and Bacteremia in a Patient Undergoing Continuous Ambulatory Peritoneal Dialysis
J. Clin. Microbiol., January 1, 2010; 48(1): 336 - 337.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A.-M. Habib, E. Preston, and A. Davenport
Risk factors for developing encapsulating peritoneal sclerosis in the icodextrin era of peritoneal dialysis prescription
Nephrol. Dial. Transplant., December 27, 2009; (2009) gfp677v1.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
R. Mactier
PERITONITIS IS STILL THE ACHILLES' HEEL OF PERITONEAL DIALYSIS
Perit. Dial. Int., May 1, 2009; 29(3): 262 - 266.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 2009 by Multimed Inc.